# A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in South Africa

> **NCT00304668** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **International Partnership for Microbicides, Inc.**

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** dapivirine (TMC120) vaginal gel

## Key facts

- **NCT ID:** NCT00304668
- **Lead sponsor:** International Partnership for Microbicides, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00304668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00304668, "A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in South Africa". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00304668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*